Skip to content

A Study to Evaluate the Product Feasibility of Two New Silicone Hydrogel Contact Lenses

A Study to Evaluate the Product Feasibility of Two New Silicone Hydrogel Contact Lenses

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01583868
Enrollment
216
Registered
2012-04-24
Start date
2012-04-30
Completion date
2012-07-31
Last updated
2020-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Brief summary

The objective of this study is to determine the clinical feasibility and to evaluate the product performance of two RD2135-01 investigational soft contact lenses (Test 1 and Test 2) developed by Bausch + Lomb. The Test lenses will be compared to both Bausch + Lomb PureVision®2 HD (high definition) soft contact lenses and Ciba Vision Air Optix Aqua soft contact lenses when used among currently adapted soft contact lens wearers.

Interventions

DEVICEB&L RD2135-01 lens C

Lenses will be worn on a daily wear basis for 1 week. Lens care solution and lens cases will be provided for daily rinsing, cleaning, disinfecting, and storing the lenses. Rewetting drops will be provided for use as needed during the study.

DEVICEB&L RD2135-01 lens D

Lenses will be worn on a daily wear basis for 1 week. Lens care solution and lens cases will be provided for daily rinsing, cleaning, disinfecting, and storing the lenses. Rewetting drops will be provided for use as needed during the study.

DEVICEPureVision2

Lenses will be worn on a daily wear basis for 1 week. Lens care solution and lens cases will be provided for daily rinsing, cleaning, disinfecting, and storing the lenses. Rewetting drops will be provided for use as needed during the study.

Lenses will be worn on a daily wear basis for 1 week. Lens care solution and lens cases will be provided for daily rinsing, cleaning, disinfecting, and storing the lenses. Rewetting drops will be provided for use as needed during the study.

Sponsors

Bausch & Lomb Incorporated
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Have physiologically normal anterior segments not exhibiting clinically significant biomicroscopy findings. * Be adapted wearers of soft contact lenses, wear a lens in each eye, and each lens must be of the same manufacture and brand. * Be correctable through spherocylindrical refraction to 32 letters (0.3 logMAR) or better (distance, high contrast) in each eye. * Be myopic and require lens correction from -0.50 diopters (D) to -6.00 D in each eye. * Must agree to wear the study lenses on a daily wear basis for the duration of the study. * Must be willing to use a lens care system on a regular basis. * If the subject requires a Washout Period, the subject must be willing to discontinue contact lens wear and be willing to wear either spectacles or no lenses during this Washout Period.

Exclusion criteria

* Not correctable to 32 letters (0.3 logMAR) in each eye with soft spherical contact lenses. * Have an active ocular disease, any corneal infiltrative response or are using any ocular medications. * Have worn gas permeable (GP) contact lenses within last 30 days or PMMA lenses within last 3 months. * Any scar or neovascularization within the central 4mm of the cornea. * Any Grade 2 or greater finding during the slit lamp examination, Subjects with corneal infiltrates, of ANY GRADE, are not eligible. * Any Present finding during the slit lamp examination that, in the Investigator's judgment, interferes with contact lens wear. * Anisometropia (spherical equivalent) of greater than 2.00 D. * Any systemic disease affecting ocular health. * Using any systemic or topical medications that will affect ocular physiology or lens performance. * Aphakic. * Amblyopic. * Allergic to any component in the study products. * Have had any corneal surgery (ie, refractive surgery). * Currently wear monovision correction, multifocal, or toric contact lenses. * Ocular astigmatism greater than 1.00 D in either eye.

Design outcomes

Primary

MeasureTime frameDescription
Visual AcuityAt 1 week follow upVisual acuity was assessed by distance high contrast logarithm of the minimum angle of resolution (logMAR).

Secondary

MeasureTime frameDescription
Symptoms and ComplaintsAt 1 Week follow upSymptoms/complaints were assessed on a scale from 0 to 100, with 0 denoting unfavorable symptoms/complaints. Symptoms/complaints were recorded for each eye based on the participant's experience with their study lenses worn for that respective treatment period. Symptoms/complaints parameters included the following: Burning/stinging upon insertion, Comfort upon insertion, Overall comfort, Comfort at end of day, Ease of handling/insertion, Ease of handling/removal, Dryness, Itchiness, Redness, Vision upon insertion, Vision, Vision in low light, Lens cleanness upon insertion, Lens cleanness upon removal, Lens cleanness, Dryness at end of day, and Overall impression.

Countries

United States

Participant flow

Recruitment details

This was a randomized, bilateral, study, with a crossover at one week and a second crossover at two weeks. A total of 216 subjects (432 eyes) were enrolled in this study. Participants were randomized to receive either, the Test Lens C, Test Lens D and PureVision2 lenses, or the Test Lens C, Test Lens D and Air Optix Aqua lenses.

Participants by arm

ArmCount
B&L RD2135-01 Lens C Then B&L RD2135-01 Lens D Then PureVision
B&L RD2135-01 Lens C for one week then B&L RD2135-01 Lens D for one week then PureVision2 for one week
105
B&L RD2135-01 Lens C Then B&L RD2135-01 Lens D Then Ciba Vis
B&L RD2135-01 Lens C for one week then B&L RD2135-01 Lens D for one week then Ciba Vision for one week
105
Total210

Baseline characteristics

CharacteristicB&L RD2135-01 Lens C Then B&L RD2135-01 Lens D Then PureVisionB&L RD2135-01 Lens C Then B&L RD2135-01 Lens D Then Ciba VisTotal
Age, Continuous31.3 years
STANDARD_DEVIATION 8.55
31.8 years
STANDARD_DEVIATION 8.68
31.5 years
STANDARD_DEVIATION 8.6
Sex: Female, Male
Female
72 Participants71 Participants143 Participants
Sex: Female, Male
Male
33 Participants34 Participants67 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —— / —
other
Total, other adverse events
0 / 2120 / 2120 / 1060 / 106
serious
Total, serious adverse events
0 / 2120 / 2120 / 1060 / 106

Outcome results

Primary

Visual Acuity

Visual acuity was assessed by distance high contrast logarithm of the minimum angle of resolution (logMAR).

Time frame: At 1 week follow up

Population: There were 212 eligible, dispensed participants (424 eyes). Participants/eyes received multiple treatment groups in this cross-over study. All eyes received investigational lens C and investigation lens D. Half of the eyes received PureVision2 and half of the eyes received Ciba Vision Air Optix Aqua.

ArmMeasureValue (MEAN)Dispersion
B&L RD2135-01 Lens CVisual Acuity-0.089 logMARStandard Deviation 0.078
B&L RD2135-01 Lens DVisual Acuity-0.087 logMARStandard Deviation 0.079
PureVision2Visual Acuity-0.086 logMARStandard Deviation 0.077
Ciba Vision Air Optix AquaVisual Acuity-0.086 logMARStandard Deviation 0.082
Secondary

Symptoms and Complaints

Symptoms/complaints were assessed on a scale from 0 to 100, with 0 denoting unfavorable symptoms/complaints. Symptoms/complaints were recorded for each eye based on the participant's experience with their study lenses worn for that respective treatment period. Symptoms/complaints parameters included the following: Burning/stinging upon insertion, Comfort upon insertion, Overall comfort, Comfort at end of day, Ease of handling/insertion, Ease of handling/removal, Dryness, Itchiness, Redness, Vision upon insertion, Vision, Vision in low light, Lens cleanness upon insertion, Lens cleanness upon removal, Lens cleanness, Dryness at end of day, and Overall impression.

Time frame: At 1 Week follow up

Population: There were 212 eligible, dispensed participants (424 eyes). Participants/eyes received multiple treatment groups in this cross-over study. All eyes received investigational lens C and investigation lens D. Half of the eyes received PureVision2 and half of the eyes received Ciba Vision Air Optix Aqua.

ArmMeasureGroupValue (LEAST_SQUARES_MEAN)Dispersion
B&L RD2135-01 Lens CSymptoms and ComplaintsRedness92.4 score on a scaleStandard Deviation 11.7
B&L RD2135-01 Lens CSymptoms and ComplaintsOverall comfort88.0 score on a scaleStandard Deviation 14.6
B&L RD2135-01 Lens CSymptoms and ComplaintsVision upon insertion93.4 score on a scaleStandard Deviation 9.6
B&L RD2135-01 Lens CSymptoms and ComplaintsBurning/stinging upon insertion91.3 score on a scaleStandard Deviation 13.1
B&L RD2135-01 Lens CSymptoms and ComplaintsVision92.3 score on a scaleStandard Deviation 11.4
B&L RD2135-01 Lens CSymptoms and ComplaintsOverall impression84.5 score on a scaleStandard Deviation 17
B&L RD2135-01 Lens CSymptoms and ComplaintsLens cleanness91.8 score on a scaleStandard Deviation 10.6
B&L RD2135-01 Lens CSymptoms and ComplaintsVision in low light91.0 score on a scaleStandard Deviation 11.9
B&L RD2135-01 Lens CSymptoms and ComplaintsLens cleanness upon insertion93.1 score on a scaleStandard Deviation 10.9
B&L RD2135-01 Lens CSymptoms and ComplaintsComfort at end of day81.2 score on a scaleStandard Deviation 18.9
B&L RD2135-01 Lens CSymptoms and ComplaintsEase of handling/insertion89.5 score on a scaleStandard Deviation 16.6
B&L RD2135-01 Lens CSymptoms and ComplaintsComfort upon insertion89.6 score on a scaleStandard Deviation 14.5
B&L RD2135-01 Lens CSymptoms and ComplaintsEase of handling/removal91.1 score on a scaleStandard Deviation 14.3
B&L RD2135-01 Lens CSymptoms and ComplaintsDryness84.4 score on a scaleStandard Deviation 16.1
B&L RD2135-01 Lens CSymptoms and ComplaintsLens cleannes upon removal89.9 score on a scaleStandard Deviation 12.2
B&L RD2135-01 Lens CSymptoms and ComplaintsDryness at end of day82.4 score on a scaleStandard Deviation 17.7
B&L RD2135-01 Lens CSymptoms and ComplaintsItchiness90.6 score on a scaleStandard Deviation 12.9
B&L RD2135-01 Lens DSymptoms and ComplaintsDryness at end of day80.3 score on a scaleStandard Deviation 19.3
B&L RD2135-01 Lens DSymptoms and ComplaintsComfort at end of day79.3 score on a scaleStandard Deviation 20.2
B&L RD2135-01 Lens DSymptoms and ComplaintsEase of handling/insertion88.6 score on a scaleStandard Deviation 17.3
B&L RD2135-01 Lens DSymptoms and ComplaintsLens cleanness91.2 score on a scaleStandard Deviation 11.7
B&L RD2135-01 Lens DSymptoms and ComplaintsVision upon insertion91.5 score on a scaleStandard Deviation 13.3
B&L RD2135-01 Lens DSymptoms and ComplaintsBurning/stinging upon insertion91.3 score on a scaleStandard Deviation 12.4
B&L RD2135-01 Lens DSymptoms and ComplaintsOverall comfort85.7 score on a scaleStandard Deviation 16.9
B&L RD2135-01 Lens DSymptoms and ComplaintsRedness91.6 score on a scaleStandard Deviation 13.1
B&L RD2135-01 Lens DSymptoms and ComplaintsVision91.9 score on a scaleStandard Deviation 13.1
B&L RD2135-01 Lens DSymptoms and ComplaintsEase of handling/removal91.0 score on a scaleStandard Deviation 13.6
B&L RD2135-01 Lens DSymptoms and ComplaintsOverall impression82.2 score on a scaleStandard Deviation 19
B&L RD2135-01 Lens DSymptoms and ComplaintsVision in low light89.9 score on a scaleStandard Deviation 13.4
B&L RD2135-01 Lens DSymptoms and ComplaintsLens cleannes upon removal89.3 score on a scaleStandard Deviation 12.9
B&L RD2135-01 Lens DSymptoms and ComplaintsComfort upon insertion88.2 score on a scaleStandard Deviation 15.6
B&L RD2135-01 Lens DSymptoms and ComplaintsItchiness89.6 score on a scaleStandard Deviation 15.9
B&L RD2135-01 Lens DSymptoms and ComplaintsLens cleanness upon insertion92.8 score on a scaleStandard Deviation 11.4
B&L RD2135-01 Lens DSymptoms and ComplaintsDryness81.9 score on a scaleStandard Deviation 18.1
PureVision2Symptoms and ComplaintsLens cleanness upon insertion89.7 score on a scaleStandard Deviation 14.6
PureVision2Symptoms and ComplaintsLens cleannes upon removal86.3 score on a scaleStandard Deviation 17.2
PureVision2Symptoms and ComplaintsLens cleanness86.6 score on a scaleStandard Deviation 17
PureVision2Symptoms and ComplaintsComfort at end of day72.0 score on a scaleStandard Deviation 22.9
PureVision2Symptoms and ComplaintsDryness at end of day75.5 score on a scaleStandard Deviation 21.7
PureVision2Symptoms and ComplaintsOverall impression73.7 score on a scaleStandard Deviation 24.6
PureVision2Symptoms and ComplaintsEase of handling/insertion85.0 score on a scaleStandard Deviation 20.4
PureVision2Symptoms and ComplaintsEase of handling/removal89.4 score on a scaleStandard Deviation 15.6
PureVision2Symptoms and ComplaintsDryness77.0 score on a scaleStandard Deviation 21.6
PureVision2Symptoms and ComplaintsComfort upon insertion78.7 score on a scaleStandard Deviation 15.6
PureVision2Symptoms and ComplaintsItchiness87.4 score on a scaleStandard Deviation 17
PureVision2Symptoms and ComplaintsRedness90.6 score on a scaleStandard Deviation 14
PureVision2Symptoms and ComplaintsVision upon insertion87.0 score on a scaleStandard Deviation 17.5
PureVision2Symptoms and ComplaintsVision88.1 score on a scaleStandard Deviation 14.6
PureVision2Symptoms and ComplaintsOverall comfort78.4 score on a scaleStandard Deviation 20.4
PureVision2Symptoms and ComplaintsVision in low light87.3 score on a scaleStandard Deviation 13.8
PureVision2Symptoms and ComplaintsBurning/stinging upon insertion83.1 score on a scaleStandard Deviation 21.4
Ciba Vision Air Optix AquaSymptoms and ComplaintsOverall impression83.9 score on a scaleStandard Deviation 18.3
Ciba Vision Air Optix AquaSymptoms and ComplaintsBurning/stinging upon insertion92.6 score on a scaleStandard Deviation 9.9
Ciba Vision Air Optix AquaSymptoms and ComplaintsComfort upon insertion89.6 score on a scaleStandard Deviation 12
Ciba Vision Air Optix AquaSymptoms and ComplaintsOverall comfort86.6 score on a scaleStandard Deviation 15.8
Ciba Vision Air Optix AquaSymptoms and ComplaintsComfort at end of day79.7 score on a scaleStandard Deviation 19.7
Ciba Vision Air Optix AquaSymptoms and ComplaintsEase of handling/insertion89.0 score on a scaleStandard Deviation 15.3
Ciba Vision Air Optix AquaSymptoms and ComplaintsEase of handling/removal89.4 score on a scaleStandard Deviation 15.5
Ciba Vision Air Optix AquaSymptoms and ComplaintsDryness84.4 score on a scaleStandard Deviation 17.3
Ciba Vision Air Optix AquaSymptoms and ComplaintsItchiness88.5 score on a scaleStandard Deviation 17.3
Ciba Vision Air Optix AquaSymptoms and ComplaintsRedness91.2 score on a scaleStandard Deviation 12.5
Ciba Vision Air Optix AquaSymptoms and ComplaintsVision upon insertion93.1 score on a scaleStandard Deviation 9.6
Ciba Vision Air Optix AquaSymptoms and ComplaintsVision93.5 score on a scaleStandard Deviation 10.3
Ciba Vision Air Optix AquaSymptoms and ComplaintsVision in low light91.4 score on a scaleStandard Deviation 12.5
Ciba Vision Air Optix AquaSymptoms and ComplaintsLens cleanness upon insertion94.4 score on a scaleStandard Deviation 7.7
Ciba Vision Air Optix AquaSymptoms and ComplaintsLens cleannes upon removal90.9 score on a scaleStandard Deviation 9.7
Ciba Vision Air Optix AquaSymptoms and ComplaintsLens cleanness92.5 score on a scaleStandard Deviation 9.1
Ciba Vision Air Optix AquaSymptoms and ComplaintsDryness at end of day82.4 score on a scaleStandard Deviation 17.3

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026